Dukascopy Europe IBS AS is a European Union licensed Investment Brokerage Company, which is regulated by the Latvijas Banka, the central bank of Latvia, the competent authority for investment services supervision in Latvia.
According to Investor Protection Law of the Republic of Latvia and Investor Compensation Schemes Directive
In order to receive the compensation, the client shall submit an application to Latvijas Banka. The application shall be submitted in accordance with the application submission procedure specified by the Latvijas Banka − within a one-year period from the date when the client has become aware of the default by Dukascopy Europe on obligations, but no later than five years from the date of default on obligations. Latvijas Banka shall make a decision on the validity of the compensation payment or on the refusal to pay compensation within a 30-day period from the date of application submission.
Further information is available on the Latvijas Banka website.
In accordance with the Financial Instrument Market Law (Article 126.²), in order to determine the appropriateness of investment service for the interests of an investor, an investment brokerage firm shall request information from the client or potential client regarding his or her experience and knowledge in the investment field in relation to the particular investment service or product offered or requested.
Dukascopy Europe IBS AS requires all clients to undergo the MiFID II Appropriateness Test, which is the process of collecting information about the client’s experience and knowledge of financial instruments. The answers provided by clients help assessing if the trading instruments offered by Dukascopy Europe IBS AS are appropriate to every client’s profile.
Dukascopy Europe IBS AS stores customer funds separately from its own funds, on a segregated bank account.
Dukascopy Europe IBS AS uses customer funds exclusively to ensure the customer’s transactions in financial instruments pursuant to a written contract signed by the customer and Dukascopy Europe IBS AS.
The funds belonging to a customer of Dukascopy Europe IBS AS cannot be used to meet creditor claims on Dukascopy Europe IBS AS. This condition would also apply in case of insolvency of Dukascopy Europe IBS AS.
Should your funds be managed by a money manager or by any other third party, Dukascopy Europe IBS AS gives you the unique opportunity to limit the possible losses on your account through its "Equity Stop-Loss" functionality. Should your account reach the Stop-Loss level set by you, the trading would be instantly deactivated and all open positions would be closed to protect your remaining capital against further losses.
Additionally, Dukascopy Europe IBS AS gives you the possibility to instantly interrupt the trading performed on your account by your PAMM manager and to close all open positions by simply accessing a button on your online report.
Please be informed that in order to have your account managed by a third party, including any close person of you, you must grant and sign a power of attorney in favor of the latter.
Dukascopy Europe IBS AS strives to offer you the best possible risk management tools to trade safely on volatile markets.
By using the Slippage Control Functionality you may preselect the maximum negative slippage that can affect the execution price of your orders. You may even totally exclude any negative slippage. However, keep in mind that reducing tolerance to slippage increases the probability of an order reject.
Feel free to contact us for more information about the Slippage Control Functionality and consult the Wiki.
Third parties such as Money Managers or Service Providers should never request your personal access codes but shall require special access rights directly from Dukascopy Europe IBS AS. By communicating your access codes to third parties, you would not only breach Dukascopy Europe’s terms and conditions but you would seriously expose your own funds to the risk of misuse / misappropriation. Furthermore, unknown persons to Dukascopy Europe cannot obtain any assistance from our Trading Support Desk that may harm your funds, e.g. in case a position on your account needs to be closed urgently while Internet access to the SWFX trading system is not available.
For the safety of your money, investment opportunities shall be assessed with a tendency toward scepticism. Dukascopy Europe IBS AS recommends cautiousness, especially regarding the following:
Your account becomes "Dormant" if Dukascopy Europe IBS AS is no longer able to contact you. This may happen, in particular, if you change your domicile / contact details without informing us or if you pass away without appointing any attorney on your account who can be contacted. In case of dormancy, it might be difficult or impossible for Dukascopy Europe IBS AS to reestablish contact with you / your heirs. In order to avoid dormancy, Dukascopy Europe IBS AS recommends that you:
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71.08% of retail investor accounts lose money when trading CFDs with this provider. Show more You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Show less